1.59
price up icon0.63%   0.01
after-market Dopo l'orario di chiusura: 1.58 -0.01 -0.63%
loading
Precedente Chiudi:
$1.58
Aprire:
$1.55
Volume 24 ore:
1.01M
Relative Volume:
0.89
Capitalizzazione di mercato:
$97.60M
Reddito:
$5.03M
Utile/perdita netta:
$-185.41M
Rapporto P/E:
-0.5146
EPS:
-3.09
Flusso di cassa netto:
$-139.79M
1 W Prestazione:
+11.97%
1M Prestazione:
+22.31%
6M Prestazione:
-85.44%
1 anno Prestazione:
-87.47%
Intervallo 1D:
Value
$1.545
$1.615
Intervallo di 1 settimana:
Value
$1.395
$1.64
Portata 52W:
Value
$1.1001
$16.10

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
Nome
Pliant Therapeutics Inc
Name
Telefono
650-481-6770
Name
Indirizzo
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
Dipendente
171
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PLRX's Discussions on Twitter

Confronta PLRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PLRX
Pliant Therapeutics Inc
1.59 96.99M 5.03M -185.41M -139.79M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-04 Ripresa Cantor Fitzgerald Neutral
2025-03-04 Downgrade Needham Buy → Hold
2025-03-03 Downgrade Leerink Partners Outperform → Market Perform
2025-03-03 Downgrade Stifel Buy → Hold
2025-02-10 Downgrade Canaccord Genuity Buy → Hold
2025-02-10 Downgrade Citigroup Buy → Neutral
2025-02-10 Downgrade H.C. Wainwright Buy → Neutral
2025-02-10 Downgrade JP Morgan Overweight → Neutral
2025-02-10 Downgrade Oppenheimer Outperform → Perform
2025-02-10 Downgrade RBC Capital Mkts Outperform → Sector Perform
2025-02-10 Downgrade Wells Fargo Overweight → Equal Weight
2024-09-09 Ripresa Leerink Partners Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2023-05-18 Iniziato Canaccord Genuity Buy
2023-04-13 Iniziato Robert W. Baird Outperform
2022-12-14 Iniziato Stifel Buy
2022-12-07 Iniziato JP Morgan Overweight
2022-09-01 Iniziato Citigroup Buy
2022-07-20 Iniziato SVB Leerink Outperform
2022-05-25 Iniziato Cantor Fitzgerald Overweight
2021-12-10 Iniziato Oppenheimer Outperform
2021-11-24 Iniziato RBC Capital Mkts Outperform
2021-11-03 Iniziato H.C. Wainwright Buy
2021-04-20 Iniziato BTIG Research Buy
2021-04-05 Iniziato Citigroup Buy
2020-06-29 Iniziato Citigroup Buy
2020-06-29 Iniziato Cowen Outperform
2020-06-29 Iniziato Needham Buy
2020-06-29 Iniziato Piper Sandler Overweight
Mostra tutto

Pliant Therapeutics Inc Borsa (PLRX) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Pliant Therapeutics Inc. stockOutperformance with explosive growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Pliant Therapeutics Inc. stock priceAccelerated wealth expansion - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Pliant Therapeutics Inc. Stock Analysis and ForecastRapid-fire capital growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Pliant Therapeutics Inc. a good long term investmentMarket-beating performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Is Pliant Therapeutics Inc. stock a growth or value playHigh Return Potential - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Pliant Therapeutics Inc. stock price move sharplyDefensive Stock Picks with Upside - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

How Pliant Therapeutics Inc. stock performs during market volatilityTrade Ready Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Pliant Therapeutics Inc. stock attracts strong analyst attentionLow Risk ROI Maximization - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Pliant Therapeutics Inc (PLRX) Stock: Navigating a Year of Volatility - investchronicle.com

Jul 10, 2025
pulisher
Jul 03, 2025

Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Apellis Pharmaceuticals (APLS) and Pliant Therapeutics (PLRX) - The Globe and Mail

Jul 03, 2025
pulisher
Jul 01, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sangamo Biosciences (SGMO), Pliant Therapeutics (PLRX) and Stevanato Group (STVN) - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Pliant Therapeutics, Inc.(NasdaqGS: PLRX) dropped from Russell 2500 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock - The Manila Times

Jun 28, 2025
pulisher
Jun 27, 2025

Pliant Therapeutics Provides Update on BEACON-IPF | PLRX Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewswire

Jun 27, 2025
pulisher
Jun 27, 2025

Pliant Therapeutics Provides Update on BEACON-IPF | PLRX Stock N - GuruFocus

Jun 27, 2025
pulisher
Jun 14, 2025

Pliant Therapeutics Inc’s (PLRX) Stock Is Harder To Predict Than You Think - Stocksregister

Jun 14, 2025
pulisher
Jun 10, 2025

Pliant Therapeutics amends corporate bylaws, holds stockholder vote By Investing.com - Investing.com Nigeria

Jun 10, 2025
pulisher
Jun 09, 2025

Pliant Therapeutics amends corporate bylaws, holds stockholder vote - Investing.com

Jun 09, 2025
pulisher
May 21, 2025

Pliant Therapeutics presents new fibrosis treatment data By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at th - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Pliant Therapeutics presents new fibrosis treatment data - Investing.com

May 21, 2025
pulisher
May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference | PLRX Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society ... - Eagle-Tribune

May 21, 2025
pulisher
May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference - GlobeNewswire

May 21, 2025
pulisher
May 14, 2025

How Are Things Looking For Pliant Therapeutics Inc (NASDAQ: PLRX) For The Short Term? - Stocksregister

May 14, 2025
pulisher
May 12, 2025

Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties - TipRanks

May 12, 2025
pulisher
May 09, 2025

Another Bay Area biotech company announces layoffs - MSN

May 09, 2025
pulisher
May 09, 2025

Pliant Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 09, 2025

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - The Manila Times

May 09, 2025

Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):